Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4

Por Foster, David J R, Somogyi, Andrew A, Bochner, Felix
Publicado em 1999

Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids

Por Morrish, Glynn A, Foster, David J R, Somogyi, Andrew A
Publicado em 2006

Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion Method

Por Bazargan, Maryam, Foster, David J. R., Davey, Andrew K., Muhlhausler, Beverly S.
Publicado no Drugs R D (2017)

Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients

Por Foster, David J R, Somogyi, Andrew A, White, Jason M, Bochner, Felix
Publicado em 2004

Population Pharmacokinetic Modeling of Itraconazole and Hydroxyitraconazole for Oral SUBA-Itraconazole and Sporanox Capsule Formulations in Healthy Subjects in Fed and Fasted State...

Por Abuhelwa, Ahmad Y., Foster, David J. R., Mudge, Stuart, Hayes, David, Upton, Richard N.
Publicado no Antimicrob Agents Chemother (2015)

Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats

Por Leshinsky, Jana, McLachlan, Andrew, Foster, David J. R., Norris, Ross, Barrs, Vanessa R.
Publicado no PLoS One (2017)

CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes

Por Hutchinson, Mark R, Menelaou, Andrew, Foster, David J R, Coller, Janet K, Somogyi, Andrew A
Publicado em 2004

Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients

Por Foster, David J R, Somogyi, Andrew A, Dyer, Kyle R, White, Jason M, Bochner, Felix
Publicado em 2000

A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine

Por Wojciechowski, Jessica, Wiese, Michael D, Proudman, Susanna M, Foster, David J R, Upton, Richard N
Publicado no Br J Clin Pharmacol (2015)

A model‐based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity

Por Wojciechowski, Jessica, Wiese, Michael D., Proudman, Susanna M., Foster, David J. R., Upton, Richard N.
Publicado no Br J Clin Pharmacol (2016)

Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre

Por Jittiwutikarn, Jaroon, Ali, Robert, White, Jason M, Bochner, Felix, Somogyi, Andrew A, Foster, David J R
Publicado em 2004

(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy

Por Gordon, Andrea L, Lopatko, Olga V, Somogyi, Andrew A, Foster, David J R, White, Jason M
Publicado em 2010

Blood–brain equilibration kinetics of levo-α-acetyl-methadol using a chronically instrumented sheep preparation

Por Foster, David J R, Jensen, Mette L, Upton, Richard N, Somogyi, Andrew A, Grant, Cliff, Martinez, Allison
Publicado em 2005

Population Pharmacokinetic Model of Doxycycline Plasma Concentrations Using Pooled Study Data

Por Hopkins, Ashley M., Wojciechowski, Jessica, Abuhelwa, Ahmad Y., Mudge, Stuart, Upton, Richard N., Foster, David J. R.
Publicado no Antimicrob Agents Chemother (2017)

Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis

Por Hopkins, Ashley M., Wiese, Michael D., Proudman, Susanna M., O'Doherty, Catherine E., Upton, Richard N., Foster, David J. R.
Publicado no Br J Clin Pharmacol (2015)